Atıf Formatları
Combined treatment with ruxolitinib and MK-2206 inhibits metastasis in MDA-MB-231 breast cancer cell line via downregulating ATG5 and DNMT1
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

E. GÜVENİR ÇELİK And O. EROĞLU, "Combined treatment with ruxolitinib and MK-2206 inhibits metastasis in MDA-MB-231 breast cancer cell line via downregulating ATG5 and DNMT1," 26. Ulusal Elektron Mikroskopi Kongresi , Turkey, 2023

GÜVENİR ÇELİK, E. And EROĞLU, O. 2023. Combined treatment with ruxolitinib and MK-2206 inhibits metastasis in MDA-MB-231 breast cancer cell line via downregulating ATG5 and DNMT1. 26. Ulusal Elektron Mikroskopi Kongresi , (Turkey).

GÜVENİR ÇELİK, E., & EROĞLU, O., (2023). Combined treatment with ruxolitinib and MK-2206 inhibits metastasis in MDA-MB-231 breast cancer cell line via downregulating ATG5 and DNMT1 . 26. Ulusal Elektron Mikroskopi Kongresi, Turkey

GÜVENİR ÇELİK, ESİN, And ONUR EROĞLU. "Combined treatment with ruxolitinib and MK-2206 inhibits metastasis in MDA-MB-231 breast cancer cell line via downregulating ATG5 and DNMT1," 26. Ulusal Elektron Mikroskopi Kongresi, Turkey, 2023

GÜVENİR ÇELİK, ESİN G. And EROĞLU, ONUR. "Combined treatment with ruxolitinib and MK-2206 inhibits metastasis in MDA-MB-231 breast cancer cell line via downregulating ATG5 and DNMT1." 26. Ulusal Elektron Mikroskopi Kongresi , Turkey, 2023

GÜVENİR ÇELİK, E. And EROĞLU, O. (2023) . "Combined treatment with ruxolitinib and MK-2206 inhibits metastasis in MDA-MB-231 breast cancer cell line via downregulating ATG5 and DNMT1." 26. Ulusal Elektron Mikroskopi Kongresi , Turkey.

@conferencepaper{conferencepaper, author={ESİN GÜVENİR ÇELİK And author={ONUR EROĞLU}, title={Combined treatment with ruxolitinib and MK-2206 inhibits metastasis in MDA-MB-231 breast cancer cell line via downregulating ATG5 and DNMT1}, congress name={26. Ulusal Elektron Mikroskopi Kongresi}, city={}, country={Turkey}, year={2023}}